首页> 外文期刊>Clinical chemistry and laboratory medicine: CCLM >Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP.
【24h】

Tests for the measurement of factor VII-activating protease (FSAP) activity and antigen levels in citrated plasma, their correlation to PCR testing, and utility for the detection of the Marburg I-polymorphism of FSAP.

机译:用于测量柠檬酸血浆中的VII因子激活蛋白酶(FSAP)活性和抗原水平,与PCR测试的相关性以及可用于检测FSAP的Marburg I多态性的测试。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The single nucleotide Marburg I (MRI) polymorphism of the factor VII-activating protease (FSAP) gene, the prourokinase-activating activity of FSAP, and antigen levels of FSAP in plasma have been associated with incidence and progression of carotid stenosis and venous thromboembolism. However, more information on the extent of these associations, potential further ones, and respective clinical utilities remain to be determined. At present, testing is performed mainly by PCR assays based on probes or SYBR Green I. Some studies include testing for antigen levels of total FSAP and its ability to activate prourokinase. To test large cohorts, it is beneficial to rely on assays that are cost-effective, reliable, easy to use, rapid to perform, and that may eventually be automated. In addition, it appears advantageous to use functional tests or tests that determine antigen levels as they may relate more closely to the phenotype than the genotype does. METHODS: Tests for the measurements of antigen levels of FSAP and its prourokinase-activating activity were improved and performance characteristics assessed. To determine the FSAP genotypes, an amplification created restriction site (ACRS) PCR test was developed. RESULTS: Key performance characteristics of the FSAP activity and antigen tests were as follows: measuring range: 350-1400 mPEU/mL and 1.8-120 ng/mL, total coefficients of variation (CV): 5%-20% and 5%-14%, within-run CV: 4%-11% and 2.3%-12%, and run-to-run CV: 2%-17% and 4.3%-8.3%, respectively. The ratio of the activity and antigen level of FSAP correctly identified the FSAP genotypes of 126 samples tested. CONCLUSIONS: The ACRS PCR test is useful for laboratories that do not have the equipment to perform probe or SYBR Green I based real-time PCR. Furthermore, the tests developed for the determination of FSAP activity and antigen levels are convenient for determining clinical correlations, even for large population studies. The ratio of activity and antigen level of FSAP appears to be a promising and efficient alternative to molecular diagnostic techniques to detect the MRI polymorphism of FSAP.
机译:背景:VII因子激活蛋白酶(FSAP)基因的单核苷酸Marburg I(MRI)多态性,FSAP的原尿激酶激活活性以及FSAP抗原水平与颈动脉狭窄和静脉的发生和发展相关血栓栓塞。但是,有关这些关联的程度,潜在的进一步关联以及各自的临床用途的更多信息仍有待确定。目前,测试主要通过基于探针或SYBR Green I的PCR分析进行。一些研究包括测试总FSAP的抗原水平及其激活尿激酶的能力。为了测试大型队列,有益的是依赖于具有成本效益,可靠,易于使用,执行迅速且最终可以自动化的测定。另外,使用功能性测试或确定抗原水平的测试似乎是有利的,因为它们可能比基因型更接近表型。方法:改进了FSAP抗原水平及其原尿激酶激活活性的检测方法,并评估了性能特征。为了确定FSAP基因型,开发了扩增创建的限制性酶切位点(ACRS)PCR试验。结果:FSAP活性和抗原测试的主要性能特征如下:测量范围:350-1400 mPEU / mL和1.8-120 ng / mL,总变异系数(CV):5%-20%和5%- 14%,批内CV:4%-11%和2.3%-12%,批间CV:分别为2%-17%和4.3%-8.3%。 FSAP的活性和抗原水平的比率正确地确定了测试的126个样品的FSAP基因型。结论:ACRS PCR测试对没有设备进行探针或SYBR Green I实时PCR的实验室非常有用。此外,为确定FSAP活性和抗原水平而开发的测试可方便地确定临床相关性,即使对于大量人群研究也是如此。 FSAP的活性和抗原水平的比率似乎是检测FSAP MRI多态性的分子诊断技术的有希望和有效的替代方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号